Back
Syndax Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
SNDX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
40
SNDX
Syndax Pharmaceuticals
Last Price:
18.24
Seasonality Move:
-5.65%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.Syndax Pharmaceuticals Price Quote
$18.24
-0.03 (-2.09%)
(Updated: September 21, 2024 at 6:44 AM ET)
Syndax Pharmaceuticals Key Stats
Sell
40
Syndax Pharmaceuticals (SNDX)
is a Sell
Day range:
$18.24 - $18.69
52-week range:
$11.22 - $25.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.58%
Volume:
1.2M
Avg. volume:
999.9K
1-year change:
12.02%
Market cap:
$1.6B
Revenue:
$0
EPS:
$-3.38
How Much Does Syndax Pharmaceuticals Make?
Data Unavailable
Is Syndax Pharmaceuticals Growing As A Company?
Data Unavailable
Syndax Pharmaceuticals Stock Price Performance
-
Did Syndax Pharmaceuticals Stock Go Up Last Month?
Syndax Pharmaceuticals share price went down by -10.62% last month -
Did SNDX's Share Price Rise Over The Last Year?
SNDX share price rose by 12.02% over the past 1 year
What Is Syndax Pharmaceuticals 52-Week High & Low?
-
What Is Syndax Pharmaceuticals’s 52-Week High Share Price?
Syndax Pharmaceuticals has traded as high as $25.34 over the past 52 weeks -
What Is Syndax Pharmaceuticals’s 52-Week Low Share Price?
Syndax Pharmaceuticals has traded as low as $11.22 over the past 52 weeks
Syndax Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Syndax Pharmaceuticals?
-
How Much Debt Does Syndax Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Syndax Pharmaceuticals Have?
Cash and short term investments quarterly total is $432.3M -
What Is Syndax Pharmaceuticals’s Book Value Per Share?
Book value per share is 5.11
Is Syndax Pharmaceuticals Cash Flow Positive?
-
What Is SNDX Cash Flow From Operations?
Cash flow from operations (TTM) is -$241.2M -
What Is Syndax Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $263.2M -
What Is Syndax Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$13.9M
Syndax Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SNDX return on invested capital is -58.96% -
What Is Syndax Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -53.6% -
What Is SNDX Return On Equity?
ROE is a measure of profitability and is -58.96%
Syndax Pharmaceuticals Earnings Date & Stock Price
-
What Is Syndax Pharmaceuticals's Stock Price Today?
A single share of SNDX can be purchased today for 18.27 -
What Is Syndax Pharmaceuticals’s Stock Symbol?
Syndax Pharmaceuticals trades on the nasdaq under the ticker symbol: SNDX -
When Is Syndax Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Syndax Pharmaceuticals is scheduled on November 1, 2024 -
When Is SNDX's next ex-dividend date?
Syndax Pharmaceuticals's next ex-dividend date is September 21, 2024 -
How To Buy Syndax Pharmaceuticals Stock?
You can buy Syndax Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Syndax Pharmaceuticals Competitors
-
Who Are Syndax Pharmaceuticals's Competitors?
Below is a list of companies who compete with Syndax Pharmaceuticals or are related in some way:
Syndax Pharmaceuticals Dividend Yield
-
What Is SNDX Dividend Yield?
Syndax Pharmaceuticals’s dividend yield currently is 0% -
What Is Syndax Pharmaceuticals’s Payout Ratio?
Syndax Pharmaceuticals’s payout ratio is 0% -
When Did Syndax Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is Syndax Pharmaceuticals’s Dividend Per Share?
Syndax Pharmaceuticals pays a dividend of $0.00 per share
Syndax Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 12.17% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 35.15 |
Upside from Last Price: | 92.41% |